LongevityMD’s Exosome Evidence Check

Field notes

LongevityMD organizes its material as clinician-attributed reporting rather than as a treatment storefront or consultation funnel. The featured article focuses on exosome therapy and explicitly contrasts a large preclinical literature with limited published human evidence, while stating that no product is FDA approved. The homepage also identifies the author as Christopher Walker, MD FICS, and advises readers to consult their own physician.